Preventing SARS-CoV-2 Infection Using Anti-spike Nanobody-IFN-β Conjugated Exosomes.

Xiabing LyuShota ImaiTomoyoshi YamanoRikinari Hanayama

Published in: Pharmaceutical research (2022)

Exosomes conjugated with nanobody-IFN-β may provide potential benefits in the treatment of COVID-19 because of the cooperative anti-viral effects of the anti-spike nanobody and the IFN-β.

Keyphrases

sars cov
immune response
dendritic cells
mesenchymal stem cells
stem cells
coronavirus disease
photodynamic therapy